Golden Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	61.02	218.85	210.89	523.49	731.57	427.93
Cash & Short-Term Investments	61.02	218.85	210.89	523.49	731.57	427.93
Cash Growth	-31.71%	3.77%	-59.71%	-28.44%	70.96%	210.53%
Accounts Receivable	4.9	2.07	2.51	3.52	2.96	2.18
Other Receivables	0.27	1.07	1.16	2.35	0.54	6.66
Receivables	5.17	3.14	3.67	5.87	3.5	8.84
Inventory	56	58.18	75.5	75	145.52	217.25
Prepaid Expenses	9.23	10.44	15.01	15.71	9.8	14.7
Other Current Assets	23.78	28	19.29	69.57	167.76	49.2
Total Current Assets	155.19	318.6	324.36	689.63	1,058	717.92
Property, Plant & Equipment	334.09	343.83	340.56	361.42	371.81	407.58
Other Intangible Assets	29.38	28.57	27.75	28.96	28.47	33.41
Other Long-Term Assets	28.01	31.31	21.54	23.36	29.15	25.62
Total Assets	546.67	722.3	714.21	1,103	1,488	1,185
Accounts Payable	0.33	0.35	1.66	4.46	4.13	8.07
Short-Term Debt	229.69	239.47	228	228	230	158
Current Portion of Long-Term Debt	16.68	43.34	6.6	6.6	11.61	18.03
Current Portion of Leases	15.98	15.95	12.93	13.47	11.06	17.65
Current Income Taxes Payable	-	-	0.21	0.02	0.94	3.52
Current Unearned Revenue	0.27	4.09	2.68	0.68	114.5	0.36
Other Current Liabilities	24.36	41.85	33.39	49	39.02	38.23
Total Current Liabilities	287.3	345.05	285.46	302.23	411.26	243.86
Long-Term Debt	36.27	37.39	16.53	23.13	29.73	38.98
Long-Term Leases	29.21	31.21	7.87	13.34	10.73	21.42
Pension & Post-Retirement Benefits	3.39	2.89	2.25	-	-	-
Total Liabilities	356.17	416.54	312.11	338.7	451.72	304.26
Common Stock	1,622	1,622	1,422	1,422	1,422	1,322
Additional Paid-In Capital	-	64.2	-	-	501.7	424.91
Retained Earnings	-1,423	-1,372	-1,012	-650.42	-880.25	-861.32
Comprehensive Income & Other	-8.58	-8.36	-8.04	-7.17	-7.86	-5.59
Shareholders' Equity	190.5	305.76	402.1	764.67	1,036	880.27
Total Liabilities & Equity	546.67	722.3	714.21	1,103	1,488	1,185
Total Debt	327.82	367.36	271.93	284.54	293.14	254.08
Net Cash (Debt)	-266.8	-148.51	-61.04	238.95	438.43	173.85
Net Cash Growth	-	-	-	-45.50%	152.19%	-
Net Cash Per Share	-1.66	-0.99	-0.43	1.68	3.31	1.38
Filing Date Shares Outstanding	162.23	162.23	142.23	142.23	142.23	132.23
Total Common Shares Outstanding	162.23	162.23	142.23	142.23	142.23	132.23
Working Capital	-132.12	-26.45	38.9	387.4	646.89	474.06
Book Value Per Share	1.17	1.88	2.83	5.38	7.28	6.66
Tangible Book Value	161.12	277.19	374.35	735.71	1,007	846.86
Tangible Book Value Per Share	0.99	1.71	2.63	5.17	7.08	6.40
Land	155.72	155.72	155.72	155.72	155.72	155.72
Buildings	170.54	170.04	170.04	170.04	162.36	160.68
Machinery	329.8	256	255.63	241.35	217.05	211.54

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.